Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far

Luminal Androgen Receptor Breast Cancers (LAR BCs) are characterized by a triple negative phenotype and by the expression of Androgen Receptor (AR), coupled with luminal-like genomic features. This unique BC subtype, accounting for about 10% of all triple negative BC, has raised considerable interes...

Descripción completa

Detalles Bibliográficos
Autores principales: Stella, Stefania, Martorana, Federica, Massimino, Michele, Vitale, Silvia Rita, Manzella, Livia, Vigneri, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089148/
https://www.ncbi.nlm.nih.gov/pubmed/37056632
http://dx.doi.org/10.2147/OTT.S379867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089148/
https://www.ncbi.nlm.nih.gov/pubmed/37056632
http://dx.doi.org/10.2147/OTT.S379867

Ejemplares similares